BMC Cancer

1. WANG W, Wang H, Liu X, Xu F, et al
   E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies.
   BMC Cancer. 2025;25:880.
   

   >> Share

   
   
2. SPRAVE T, Sahlmann J, Thomsen AR, Klein D, et al
   Does severe mucositis impair oncological outcome in head and neck cancer patients? A pooled analysis of two prospective studies with long-term follow-up.
   BMC Cancer. 2025;25:909.
   

   >> Share

   
   
3. SUN N, Liu M, Xi C, Luo Q, et al
   Comparison of efficacy and prognostic impact of adjuvant (131)I therapy at 3.7 GBq and 5.55 GBq in DTC patients with unexplained sTg elevation.
   BMC Cancer. 2025;25:912.
   

   >> Share

   
   

   
   BMC Surg

4. 
   Postoperative outcomes after minimally invasive esophagectomy: an international cohort study from the Oesophagogastric Anastomosis Audit (OGAA).
   BMC Surg. 2025;25:225.
   

   >> Share

   
   

   
   Clin Cancer Res

5. BRYAN ME, Aye L, Das D, Hirayama S, et al
   Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck Cancers.
   Clin Cancer Res. 2025 May 20:OF1-OF11. doi: 10.1158/1078-0432.CCR-24-2525.
   

   >> Share

   
   
6. SIM ES, Rhoades J, Xiong K, Walsh L, et al
   Early Postoperative Minimal Residual Disease Detection with MAESTRO Is Associated with Recurrence and Worse Survival in Patients with Head and Neck Cancer.
   Clin Cancer Res. 2025 May 20:OF1-OF9. doi: 10.1158/1078-0432.CCR-25-0307.
   

   >> Share

   
   
7. CAO X, Luo ZY, Huang HY, Zhou JY, et al
   Capecitabine maintenance therapy in patients with residual nasopharyngeal carcinoma: a single-arm, phase 2 trial.
   Clin Cancer Res. 2025 May 19. doi: 10.1158/1078-0432.CCR-24-4132.
   

   >> Share

   
   

   
   Clin Nucl Med

8. RAVADA SK, Parghane RV, Malhotra G, Basu S, et al
   Atypical Presentation of Liver Metastasis in Medullary Thyroid Carcinoma: Variable Pattern and Interlesional Heterogeneity Observed on 18F-FDG, 68Ga-DOTATATE, and 68Ga-DOTA-FAPI-04 PET/CT.
   Clin Nucl Med. 2025 May 20. doi: 10.1097/RLU.0000000000005965.
   

   >> Share

   
   

   
   Dis Esophagus

9. WANG M, Wang X, Liu Z, Shen H, et al
   Recurrence patterns following neoadjuvant chemotherapy combined with immunotherapy for esophageal squamous cell carcinoma.
   Dis Esophagus. 2025;38:doaf034.
   

   >> Share

   
   
10. RICCIO F, Klarenbeek BR, Fujiwara H, Seto Y, et al
    Worldwide survey on the transcervical approach for minimally invasive treatment of esophageal cancer: results of questionnaire of the international collaborative group on transCervical Minimally Invasive Esophagectomy.
    Dis Esophagus. 2025;38:doaf035.
    

    >> Share

    
    
11. CHIEN S, Glen P
    Impact on Barrett's dysplasia yield following the introduction of capsule sponge testing versus traditional endoscopic surveillance.
    Dis Esophagus. 2025;38:doaf033.
    

    >> Share

    
    
12. VISSAPRAGADA R, Bulamu NB, Whiteman DC, Bright T, et al
    Computing lifetime incidence of esophageal adenocarcinoma and age-specific prevalence of Barrett's esophagus.
    Dis Esophagus. 2025;38:doaf038.
    

    >> Share

    
    

    
    Head Neck

13. KIM Y, Cho H, Choi N, Chung MK, et al
    Impact of Prior Neck Treatment Status on Salvage Treatment Outcomes in Isolated Regional Recurrence of Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2025 May 19. doi: 10.1002/hed.28191.
    

    >> Share

    
    
14. VASUDEVAN SS, Alvarez IA, Nathan CO, Pang J, et al
    Early Death in T3-T4 Head and Neck Cancer: NCDB Comparison of Surgical vs. Non-Surgical Approaches.
    Head Neck. 2025 May 19. doi: 10.1002/hed.28193.
    

    >> Share

    
    

    
    HNO

15. HANSEN S, Kansy B, Brandau S, Epple M, et al
    [Current aspects of nanoparticle-based therapy in head and neck cancer].
    HNO. 2025 May 19. doi: 10.1007/s00106-025-01633.
    

    >> Share

    
    
16. DURR S, Stangl P, Vester S, Kunzel J, et al
    [Psychological stress and psychiatric comorbidities in the treatment of dysphagia in patients with head and neck cancer].
    HNO. 2025;73:382-386.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

17. MCDOWELL L, Gough K, Fua T, Coleman A, et al
    Final Results From a Longitudinal Observation Study Evaluating Sexual Health and Facial Appearance and Distress in Human Papillomavirus-Associated Oropharyngeal Cancer Survivors Treated With Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2025;122:355-364.
    

    >> Share

    
    
18. MORENO AC, Watson EE, Humbert-Vidan L, Peterson DE, et al
    International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi Study.
    Int J Radiat Oncol Biol Phys. 2025;122:341-354.
    

    >> Share

    
    
19. FREDERIKS ML, van Etten B, Kelder W, Dieters M, et al
    Proton Radiotherapy Significantly Reduces Pneumonia in Patients With Esophageal Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:313-324.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

20. FRICH PS, Sigstad E, Berstad AE, Opsahl EM, et al
    Ethanol Ablation of Metastatic Lymph Nodes in Patients with Papillary Thyroid Carcinoma - Predictors of Clinical Outcome.
    J Clin Endocrinol Metab. 2025 May 23:dgaf298. doi: 10.1210.
    

    >> Share

    
    
21. KELLY CA, Sipos JA
    Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae722. doi: 10.1210.
    

    >> Share

    
    
22. PARVATHAREDDY SK, Siraj AK, Qadri Z, Siraj N, et al
    The Prognostic Impact of Tumor Size and BRAF Mutational Status in Middle Eastern Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Oct 18:dgae740. doi: 10.1210.
    

    >> Share

    
    
23. MENG L, Li H, Fu Y, Yu D, et al
    Somatic DICER1-Mutant Benign Thyroid Nodules in Adults: A Group of Follicular Nodular Disease With Continuous Growth.
    J Clin Endocrinol Metab. 2024 Oct 28:dgae750. doi: 10.1210.
    

    >> Share

    
    

    
    J Laryngol Otol

24. BHARDWAJ A, Suji PS, Sood R, Malhotra M, et al
    Outcomes and symptom-specific quality of life after microscopic parotidectomy: a prospective study.
    J Laryngol Otol. 2025;139:304-310.
    

    >> Share

    
    
25. SORRENTINO JM, Al Afif A, Magner WJ, Sigurdson SL, et al
    Adipofascial anterolateral thigh free flap in head and neck reconstruction: a case series.
    J Laryngol Otol. 2025;139:237-241.
    

    >> Share

    
    
26. IQBAL MS, Navarro-Rodriguez C, Munro S, Ozalp B, et al
    Patterns of care for octogenarian patients with head and neck cancer.
    J Laryngol Otol. 2025;139:320-322.
    

    >> Share

    
    

    
    Laryngoscope

27. HINTZE J, van den Berg N, Callanan D, Mohamed S, et al
    Impact of WPOI-5 on Risk of Regional Recurrence in Early Oral Cancer With pN0 Neck.
    Laryngoscope. 2025 May 21. doi: 10.1002/lary.32182.
    

    >> Share

    
    

    
    Oral Oncol

28. KIL WJ, Smith W, Cousins D
    Dosimetric comparison of oral tongue dose with tongue-out radiation therapy compared to non-tongue-out radiation therapy for head & neck cancer: Clinical implications for mitigating post-radiation therapy dysgeusia.
    Oral Oncol. 2025;165:107335.
    

    >> Share

    
    
29. AL FADEL AM, Jakobsen KK, Jensen LH, Carlander AF, et al
    The epidemiological trends and survival of HPV-related oropharyngeal cancer other than tonsils and base of tongue - a systematic review and meta-analysis.
    Oral Oncol. 2025;165:107311.
    

    >> Share

    
    
30. KUMARI S, Mishra S, Ali W, Singh US, et al
    Implication of circulating miRNAs as potential diagnostic biomarker in oropharyngeal squamous cell Carcinoma: Association with Human Papilloma Virus.
    Oral Oncol. 2025;165:107305.
    

    >> Share

    
    
31. YU N, Ma Y, Li L, Guo X, et al
    Conditional survival and dynamic failure hazard of oral cavity squamous cell carcinoma: Shedding light on the optimization of treatment and surveillance.
    Oral Oncol. 2025;165:107294.
    

    >> Share

    
    
32. BASTIEN AJ, Manzoor D, Maluf H, Balzer B, et al
    A review of histopathologic assessment for head and neck oncologists.
    Oral Oncol. 2025;165:107286.
    

    >> Share

    
    
33. TAGLIABUE M, Berardinis R, Doi G, Chu F, et al
    Tongue tumor and prognostic factors: Could a diagnostic procedure influence patient outcomes?
    Oral Oncol. 2025;165:107298.
    

    >> Share

    
    
34. JANG HB, Lee DH, Lim SC
    Treatment outcomes of sinonasal adenoid cystic carcinoma: a single-center experience.
    Oral Oncol. 2025;165:107317.
    

    >> Share

    
    
35. COSTANTINO A, Sampieri C, Haughey BH, Alamoudi U, et al
    Adjuvant treatment in elderly patients undergoing transoral surgery for HPV-related oropharyngeal cancer.
    Oral Oncol. 2025;165:107312.
    

    >> Share

    
    
36. KANO S, Kawakita D, Honma Y, Takahashi H, et al
    The impact of HER2-Low expression in salivary duct carcinoma: Clinicopathologic features, survival outcomes, and association with androgen receptor-targeted therapy.
    Oral Oncol. 2025;165:107280.
    

    >> Share

    
    
37. CHELVARAJAH RC, Liu Y, Su J, Abdalaty AH, et al
    Factors associated with detection of oligometastatic recurrence and outcome following definitive (Chemo)radiotherapy for oropharyngeal carcinoma.
    Oral Oncol. 2025;165:107310.
    

    >> Share

    
    
38. VERDONCK-DE LEEUW IM, Lissenberg-Witte BI, de Bree R, Buffart LM, et al
    The association between health-related quality of life and five-year overall survival among head and neck cancer patients: A prospective cohort study.
    Oral Oncol. 2025;166:107367.
    

    >> Share

    
    
39. BALAGURU L, Benites C, Hanubal KS, Liu G, et al
    The predictive value of tumor depth of invasion for contralateral neck disease in tongue cancer.
    Oral Oncol. 2025;165:107334.
    

    >> Share

    
    
40. RICHTER M, Doll C, Hofmann E, Reds A, et al
    The prevalence and prognostic value of CD168 in early-stage oral squamous cell carcinoma.
    Oral Oncol. 2025;165:107329.
    

    >> Share

    
    
41. GARSET-ZAMANI M, Makouei F, Agander TK, Lelkaitis G, et al
    Feasibility of 3D ultrasound for intraoperative tumor margin assessment in transoral robotic surgery for oropharyngeal squamous cell carcinoma: A pilot study.
    Oral Oncol. 2025;165:107330.
    

    >> Share

    
    
42. WEI X, Shen J, Zheng S, Dai H, et al
    Extramedullary plasmacytoma of the Gingiva: A rare case report and clinical management.
    Oral Oncol. 2025;165:107315.
    

    >> Share

    
    
43. BEDDOK A, Popovtzer A, Calugaru V, Fontaine M, et al
    Proton therapy for primary and recurrent HPV-related oropharyngeal cancer.
    Oral Oncol. 2025;165:107309.
    

    >> Share

    
    
44. OIKAWA Y, Umakoshi M, Suzuki K, Kudo-Asabe Y, et al
    Prognostic significance of cancer-associated fibroblasts and tumor-associated macrophages in the tongue squamous cell carcinoma and their correlation with tumor budding.
    Oral Oncol. 2025;165:107295.
    

    >> Share

    
    
45. KIM MJ, Koo BS, Cho KJ, Lee SH, et al
    Health-related quality-of-life assessment in patients with oropharyngeal cancer: A comparison of EQ-5D-5L and EORTC instruments.
    Oral Oncol. 2025;165:107342.
    

    >> Share

    
    
46. ECONOMOPOULOU P, Pantazopoulos T, Leventakou D, Koufopoulos N, et al
    Integrating molecular classification in adenoid cystic carcinoma of the head and neck: The experience from four tertiary centers in Greece.
    Oral Oncol. 2025;165:107341.
    

    >> Share

    
    
47. CAO F, Fang Q, Lin R, Xu P, et al
    De-escalated surgery following neoadjuvant chemoimmunotherapy for locally advanced oral squamous cell carcinoma: A retrospective cohort study.
    Oral Oncol. 2025;165:107348.
    

    >> Share

    
    
48. CRACCHIOLO JR, Starc MT, Wong RJ, Ho A, et al
    Defining response-adapted surgery after neoadjuvant therapy in oral cavity cancer.
    Oral Oncol. 2025;165:107349.
    

    >> Share

    
    
49. ZHANG J, Sun Y, Yao JQ, Liu DM, et al
    Comment on "Prognostic significance of diagnosis-to-surgery interval in oral cavity squamous cell carcinoma: A nationwide study".
    Oral Oncol. 2025;165:107352.
    

    >> Share

    
    
50. COSTANTINO A, Haughey BH, Alamoudi U, Magnuson JS, et al
    Prognostic significance of distant metastasis site at diagnosis in HPV-related oropharyngeal cancer.
    Oral Oncol. 2025;165:107361.
    

    >> Share

    
    
51. KHAN SA, Berzenji D, Gul A, Mast H, et al
    Comparison between adult comorbidity evaluation-27 and Charlson Comorbidity Index in head and neck oncology.
    Oral Oncol. 2025;165:107366.
    

    >> Share

    
    
52. VERMA S, Pizano JE, Peiris J, Verma KK, et al
    Interdisciplinary approaches to diagnosing oral cavity skin cancers: The Dentist's involvement in detecting dermatological conditions.
    Oral Oncol. 2025;165:107350.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

53. LIN HH, Chang CF, Lee TL, Hsu YB, et al
    Comparing the 7th and 8th Editions of AJCC Staging System for Hypopharyngeal Cancer Undergoing Surgery.
    Otolaryngol Head Neck Surg. 2025 May 21. doi: 10.1002/ohn.1311.
    

    >> Share

    
    

    
    PLoS One

54. LI H, Liang X, Qin S, Chen X, et al
    First-line durvalumab therapy alone or in combination with tremelimumab for metastatic head and neck squamous cell carcinoma: A cost-effectiveness analysis.
    PLoS One. 2025;20:e0324057.
    

    >> Share

    
    

    
    Radiol Artif Intell

55. WU SH, Li MD, Tong WJ, Liu YH, et al
    Adaptive Dual-Task Deep Learning for Automated Thyroid Cancer Triaging at Screening US.
    Radiol Artif Intell. 2025;7:e240271.
    

    >> Share

    
    

    
    Radiother Oncol

56. GAWRYSZUK A, van der Laan HP, Vergeer MR, Veening M, et al
    Improved NTCP model for late radiation-induced aspiration based on dose delivered to specific aspiration-related OARs.
    Radiother Oncol. 2025;207:110871.
    

    >> Share

    
    
57. HUGHES A, Johnny C, Huang SH, Su J, et al
    The prognostic and predictive value of pre-treatment hematologic markers for oropharyngeal carcinoma stratified by HPV status and treated with definitive (chemo) radiation.
    Radiother Oncol. 2025;207:110851.
    

    >> Share

    
    
58. MA B, Guo J, Dijk LVV, Langendijk JA, et al
    PET and CT based DenseNet outperforms advanced deep learning models for outcome prediction of oropharyngeal cancer.
    Radiother Oncol. 2025;207:110852.
    

    >> Share

    
    
59. YARLAGADDA S, Rohe RM, McNeill V, Nemec JR, et al
    Tubarial gland sparing for oropharyngeal cancer: Feasibility with intensity modulated proton therapy & intensity modulated radiation therapy.
    Radiother Oncol. 2025;207:110882.
    

    >> Share

    
    
60. EVANS M, Bonomo P, Chan PC, Chua MLK, et al
    Post-operative radiotherapy for oral cavity squamous cell carcinoma: Review of the data guiding the selection and the delineation of post-operative target volumes.
    Radiother Oncol. 2025;207:110880.
    

    >> Share

    
    
61. HUMBERT-VIDAN L, Kamel S, Wentzel A, Kaffey Z, et al
    Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohorts.
    Radiother Oncol. 2025;207:110890.
    

    >> Share

    
    

    
    Thyroid

62. CABANILLAS ME, Akhave N, Banuchi V, Busaidy N, et al
    Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer: The Roadmap to a Cure.
    Thyroid. 2025;35:462-470.
    

    >> Share

    
    
63. LIU S, Lu C, Li Y, Zhu L, et al
    Residential Greenness Is Associated with Lower Thyroid Nodule Prevalence: A Nationwide Study in China.
    Thyroid. 2025 Apr 23. doi: 10.1089/thy.2024.0616.
    

    >> Share

    
    
64. CHEN J, Zhong J, Zhuang Y, Deng B, et al
    Multimodality Ultrasound Utilizing Microvascular Flow Imaging and Shear Wave Elastography to Guide Fine-Needle Aspiration of Thyroid Lesions: A Prospective Study Validating Pattern-Based Microvascular Classification.
    Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0586.
    

    >> Share

    
    
65. ATHREYA S, Melehy A, Suthahar SSA, Ivezic V, et al
    Combining Ultrasound Imaging and Molecular Testing in a Multimodal Deep Learning Model for Risk Stratification of Indeterminate Thyroid Nodules.
    Thyroid. 2025 Apr 21. doi: 10.1089/thy.2024.0584.
    

    >> Share

    
    
66. RODRIGUEZ-LLOVERAS H, Zafon C, Iglesias C, Marcos-Ruiz J, et al
    DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer.
    Thyroid. 2025 Mar 6. doi: 10.1089/thy.2024.0303.
    

    >> Share

    
    
67. WU J, Stewardson P, Eszlinger M, Khalil M, et al
    Development of a Nomogram to Integrate Molecular Testing and Clinical Variables to Improve Malignancy Risk Assessment Among Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2025 Mar 5. doi: 10.1089/thy.2024.0481.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share